Andrea Giuffrida

  • 6156 Citations
  • 35 h-Index
1986 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 5 Similar Profiles
Endocannabinoids Medicine & Life Sciences
Cannabinoids Medicine & Life Sciences
Dyskinesias Medicine & Life Sciences
Schizophrenia Medicine & Life Sciences
Cannabinoid Receptor Agonists Medicine & Life Sciences
Parkinson Disease Medicine & Life Sciences
Orthoptera Medicine & Life Sciences
Cannabinoid Receptor CB1 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2004 2016

Endocannabinoid transmission in schizophrenia

Giuffrida, A.

National Institutes of Health

6/1/113/31/16

Project: Research projectResearch Project

Endocannabinoids
Schizophrenia
Cannabinoid Receptor CB1
Dronabinol
Pharmaceutical Preparations

Role of Endocannabinoids in Levodopa-Induced Dyskinesias

Giuffrida, A.

National Institutes of Health

12/15/041/31/14

Project: Research projectResearch Project

Endocannabinoids
Dyskinesias
Levodopa
Cannabinoid Receptor Agonists
Basal Ganglia

Research Output 1986 2018

  • 6156 Citations
  • 35 h-Index
  • 77 Article
  • 4 Chapter
Cannabinoids
Dopaminergic Neurons
Rodentia
Schizophrenia
Psychotic Disorders
3 Citations
Endocannabinoids
Cannabinoids
Interpersonal Relations
Cannabinoid Receptor CB1
2-(2-(5-bromo-1H-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3H)-quinazolinone

Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat model of schizophrenia

Seillier, A. & Giuffrida, A., Jul 12 2017, (Accepted/In press) In : Behavioural Pharmacology.

Research output: Contribution to journalArticle

Phencyclidine
Schizophrenia
Anxiety
Diazepam
Cannabinoid Receptor Agonists
1 Citations

The Endocannabinoid System and Parkinson Disease

Giuffrida, A. & Martinez, A., May 16 2017, The Endocannabinoid System: Genetics, Biochemistry, Brain Disorders, and Therapy. Elsevier Inc., p. 63-81 19 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Endocannabinoids
Parkinson disease
Parkinson Disease
cannabinoids
Cannabinoids
11 Citations

Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous L-DOPA delivery in the 6-OHDA model of Parkinson's disease

Mulas, G., Espa, E., Fenu, S., Spiga, S., Cossu, G., Pillai, E., Carboni, E., Simbula, G., Jadžić, D., Angius, F., Spolittu, S., Batetta, B., Lecca, D., Giuffrida, A. & Carta, A. R., Dec 1 2016, In : Experimental Neurology. 286, p. 83-92 10 p.

Research output: Contribution to journalArticle

Oxidopamine
Dyskinesias
Parkinson Disease
Corpus Striatum
Tumor Necrosis Factor-alpha